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ABSTRACT
Introduction: The aim of this study was to
assess the incidence of persistent postoperative
cystoid macular edema (pCME) in patients
undergoing pars plana vitrectomy with epireti-
nal membrane peel (ERM) only versus those
with ERM peel combined with internal limiting
membrane peel (ILM). Secondary endpoints of
the study were to review both the central mac-
ular thickness (CMT) and visual acuity.
Methods: The patients were divided in two
groups, one group in which only the ERM was
peeled (n = 36 patients) and another group in
which both the ERM and the ILM were removed
(n = 62 patients). The results were analyzed
retrospectively. Each patient received a com-
plete ophthalmological examination, including
best-corrected visual acuity (BCVA) using an
ETDRS chart and spectral domain optical
coherence tomography, at three time points:
prior to surgery and 3 weeks and 3 months after
surgery.
Results: A total 98 eyes of 98 patients were
included in this study. The mean follow-up
time was 7.7 months. CMT decreased signifi-
cantly after surgery in all patients, and none of
these changes differed significantly between the
two groups. The BCVA increased significantly
after surgery across all patients, and there were
no significant changes between the two treat-
ment groups. Postoperative pCME occurred in
eight patients in each group, representing
22.2% of the 36 patients in the ERM only group
and 12.9% of the 62 patients in the ERM/ILM
peel group. However, this difference was not
statistically significant.
Conclusions: No difference was found between
the two groups in terms of incidence of pCME.
Both groups experienced had similar decrease in
the CMT and improvement in the BCVA
postoperatively.
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INTRODUCTION
An epiretinal membrane (ERM) is a fibrocellular
tissue found on the inner surface of the retina.
It is semi-translucent and forms on the surface
of the internal limiting membrane (ILM). The
most common form of ERM is idiopathic and
occurs in elderly healthy eyes without any other
apparent disease. However, retinal breaks/de-
tachment, retinopexy and inflammation can
also lead to secondary ERM formation [1]. The
ILM is a transparent structure that defines the
boundary between the retina and the vitreous
and is the surface upon which the ERM devel-
ops. As the outer portion of the ILM is com-
posed of the footplates of the Muller cells, the
ILM acts as a rigid scaffold that transmits the
distortion caused by the ERM onto the more
flexible underlying retina. In this context, the
ILM may play a key role in the pathophysiology
of retinal disorders involving the vitreomacular
interface [2].
In general, patients with symptomatic ERM
complain of reduced and distorted vision. The
current treatment of choice for symptomatic
patients with an ERM is pars plana vitrectomy
(PPV) with ERM peel, although in the first dec-
ade of this century ERM peel combined with
removal of ILM was also routinely practiced
during during surgery on the ERM with good
anatomical results [3–6]. However, more recent
studies have shown that ILM peeling is a pro-
cedure that can cause immediate traumatic
effects and progressive modification of the
underlying inner retinal layers [7–12]. In addi-
tion, it is controversial whether ILM peeling
improves vision postoperatively faster or redu-
ces the risk of postoperative persistent CME
(pCME) [13, 14].
The aim of this study was to compare the
outcomes after ERM surgery with or without
ILM peeling in terms of vision, decrease in
central macular thickness (CMT) and compli-
cation rates, in particular the occurrence rate of
pCME.
METHODS
All procedures followed were in accordance
with the ethical standards of the institutional
and/or national research committee (NHS
Health Research Authority Bristol) and with the
1964 Helsinki declaration and its later amend-
ments or comparable ethical standards.
Informed consent was obtained from all indi-
vidual participants included in the study.
All patients who underwent PPV for ERM at
the Bristol Eye Hospital were identified and
their case notes reviewed retrospectively.
Patient with all forms of secondary ERM were
excluded. Each patient received a complete
ophthalmological examination, including best-
corrected visual acuity (BCVA) using an Early
Treatment Diabetic Retinopathy Study (ETDRS)
chart (in letters) and spectral domain–optical
coherence tomography (OCT) (Spectralis HRA
OCT; Heidelberg Engineering, Heidelberg, Ger-
many), at three time points: prior to surgery and
at 3 weeks and 3 months after surgery.
Surgical Procedure
Surgery was performed only in symptomatic
patients. A standard 3-port PPV (25-gauge)
(Constellation Vision System; Alcon Inc., Fort
Worth, TX, USA) was performed in all patients.
Dual blue dye (Geuder AG, Heidelberg, Ger-
many) was then slowly injected towards the
macular area to stain the ERM and ILM. In the
case of ILM peel, a second injection of Dual blue
dye was performed after the ERM had been
removed. A diamond brush was used to mobi-
lize the ILM. Both ERM and ILM peels were
performed in a circumferential pattern for about
1.5–2 disk diameters around the fovea using a
25G Eckardt end-gripping forceps. Patients had
an air-filled eye at the end of the surgery. In the
case of advanced cataract, a combined proce-
dure was performed with a simultaneous pha-
coemulsification. In some cases 0.05 ml of
triamcinolone acetate 40 mg/ml was injected
intravitreally at the end of surgery. All proce-
dures were performed by a team of four con-
sultants and two experienced fellows.
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Patients were examined postoperative day 1
and the intraocular pressure was checked. Fur-
ther follow-ups with an OCT were performed 3
weeks and 3 months postoperatively. The visual
acuity was tested using an ETDRS chart and
recorded in letters.
CMT was defined as the highest value on the
standard Spectralis SD-OCT retinal thickness
map. Persistent macular edema was defined as
persistent intraretinal cysts on OCT images that
remained for[ 3 months postoperatively.
Table 1 Patients’ characteristics
Patients’ characteristics Treatment group Total
ERM only group (without ILM
peel)
ERM/ILM peel group (with ILM
peel)
Number of eyes 36 62 98
Mean length of follow-up
(months)
8.6 7.1 7.7
Mean age (years) 72.3 69.0 70.2
Male (%) 67% 56% 60%
Phacoemulsiﬁcation (n)
None 10 21 31
Combined Phaco-vitrectomy 15 26 41
Previous 11 15 26
Tamponade (n)
None 15 16 31
Air 17 27 44
Gas 4 19 23
ivTA (n) 5 12 17
Best-corrected visual acuity (letters)
Preoperative 56 60 58
Postoperative at 3 weeks 62 63 63
Postoperative at 3 months 62 66 65
Last follow-up 65 69 68
Central macular thickness (lm; OCT)
Preoperative 473 476 475
Postoperative at 3 weeks 394 410 404
Postoperative at 3 months 380 373 376
Last follow-up 362 358 358
ERM Epiretinal membrane, ILM inner limiting membrane, ivTA intravitreal injection of triamcinolone, OCT optical
coherence tomography VMT vitreomacular traction,
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Data Analysis
Preoperative values of CMT and BCVA were
compared between the two treatment groups
(ERM only group; ERM/ILM peel group) using
two-sample t tests. Changes after surgery were
determined as the difference between preoper-
ative values and postoperative values at 3 weeks,
3 months and last follow-up, respectively. We
used one-sample t tests to determine whether
the mean change (for all patients) differed from
zero, and two-sample t tests to compare the two
treatment groups. To account for multiple test-
ing, we report Bonferroni–Holm-adjusted p val-
ues for the three postoperative time points. The
frequency of postoperative CME was compared
between treatment groups with a Chi-square
test. Data analysis was performed with the sta-
tistical software R, version 3.3.3 (R Foundation
for Statistical Computing, Vienna, Austria).
RESULTS
A total 98 eyes of 98 patients were included this
study. The patients were divided in two treat-
ment groups: in one group only the ERM was
peeled (ERM only group, n = 36 patients), and
in the other group both the ERM and the ILM
were removed (IERM/LM peel group, n = 62
patients). The mean follow-up time was
7.7 months. A combined procedure with catar-
act surgery was performed in 41 patients, of
whom 15 (42%) were in the ERM only group
and 26 (42%) were in the ERM/ILM peel group.
At the time of the operation, five (14%) patients
in the ERM only group and 12 (19%) patients in
the ERM/ILM peel group received an intravitreal
injection of triamcinolone acetate (ivTA).
Patients’ characteristics at baseline are summa-
rized in Table 1.
Postoperative pCME occurred in eight
patients in each group, representing 22.2% of
the 36 patients in the ERM only group and
12.9% of the 62 patients in the ERM/ILM peel
group. This difference was not statistically sig-
nificant (Chi-square 1.45, p = 0.23). None of the
17 patients who were administered an ivTA
(0%) developed pCME, whereas 16 of the 81
patients who were not administered an ivTA
(19.8%) developed pCME; this difference was
marginally significant (Chi-square 4.01,
p = 0.045). The proportion of patients develop-
ing pCME did not differ significantly between
those receiving combined phaco-vitrectomy, of
whom 19.5% had pCME, and the patients who
had no or previously performed cataract sur-
gery, of whom 14% had pCME (Chi-
square 0.52, p = 0.47).
Mean CMT did not differ significantly
between the two groups preoperatively
(473 [ERM only] vs. 465 lm [ERM/ILM peel],
t = 0.45, p = 0.70). CMT decreased significantly
after surgery in all patients, with a mean
decrease of 63.8 lm after 3 weeks (95% confi-
dence interval [CI] 48.4–79.1 lm, t = 8.3,
adjusted p\0.001), of 91.9 lm within
3 months (95% CI 72.6–111.2 lm, t = 9.5,
adjusted p\ 0.001) and of 107 lm by the last
Fig. 1 Mean change in central retinal thickness (CMT)
and best-corrected visual acuity (BVCA) in the two
treatment groups, measured for each person as the
difference from the preoperative value. Error bars represent
the standard error of the mean value (SEM). CMT Central
macular thickness, ILM inner limiting membrane, OCT
optical coherence tomography
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follow-up (95% CI 90.3–123.7 lm, t = 13.0,
adjusted p\0.001). None of these changes dif-
fered significantly between the two groups at
these three time points (adjusted p = 0.33, 1.00
and 1.00, respectively).
Mean BCVA also did not differ significantly
between the two groups preoperatively (55.9
[ERM only] vs. 59.6 letters [ERM/ILM peel],
t = 1.7, p = 0.10). The postoperative BCVA
increased significantly in all patients, with a
mean increase of 4.4 letters after 3 weeks (95%
CI 2.0–6.9, t = 3.6, adjusted p\0.001), of 6.8
letters within 3 months (95% CI 4.1–9.4, t = 5.1,
adjusted p\0.001) and of 9.1 letters at the last
follow-up (95% CI 6.4–11.9, t = 6.6, adjusted
p\0.001). Again, none of these changes dif-
fered significantly between the two treatment
groups (adjusted p = 1.00 at each follow-up)
(Fig. 1, 2). The mean improvement in BCVA at
the three follow-up time points (3 weeks, within
3 months, last follow-up) did not differ signifi-
cantly between patients receiving combined
phaco-vitrectomy and vitrectomy only patients
(adjusted p = 0.32, 1.00 and 1.00, respectively).
Not one single patient had to be re-peeled
due to the re-occurrence of ERM within the
follow-up time.
DISCUSSION
Until very recently the ILM was considered to be
an integral part of the retina, and vitreoretinal
surgeons did not think that it could be removed
without causing visual damage. However, the
publication of a number of primary reports of
cases of spontaneous separation of the ILM,
which resulted in no significant fibrosis and
good visual acuity after surgery, has driven a
change in the opinion of vitreoretinal surgeons
on the possibility of removing the ILM to
release vitreoretinal tractions [15, 16]. This
change is also driven by additional findings.
Histological studies on the removed ERM
showed that, in up to 60% of patients, the ILM
and ERM were removed together at the same
time [17, 18]. It has also been reported that ILM
specimens that were removed after ERM peeling
demonstrated the presence of microscopic ERM
remnants that persisted over the ILM in almost
one-half of the patients; these ERM remnants
could ultimately form islands of re-proliferation
[4, 18, 19, 20]. Thus, ILM removal provides the
certainty of having removed all cells that pro-
duce collagen above the retina. Additionally,
this procedure ensures that all adhesions dis-
torting the inner retina have been released.
Therefore, the simultaneous removal of ERM
and ILM has become a widely approved proce-
dure in vitreoretinal surgery. Since the early
1990s, numerous studies have confirmed that
ILM removal is associated with better anatomi-
cal improvement, better final vision outcome
and lower risk of recurrence [3–6]. In one study,
ILM peeling was also found to be the superior
surgical approach to resolving cystoid macular
edema due to less epiretinal traction, which
disappeared in 90% of the patients, compared
to 44% of patients who underwent removal of
the ERM alone [3]. However, many other com-
parison studies found no functional difference
between both groups [13, 14]. In addition, one
retrospective study found ILM removal was
correlated with worse visual outcome [21].
Fig. 2 Mean values for CMT and BVCA in the two
treatment two groups. Error bars represent the SEM
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Tadayoni et al. first reported anatomical dam-
age after ILM peeling and described a peculiar
macular appearance, called ‘‘dissociated optic
nerve fibre layer’’ (DONFL), which appears 1–3
months after surgery and leads to a thinning of
the inner retina, causing a reduction in visual
outcome [11]. Spaide et al. later clarified that
DONFL corresponds to inner retinal dimples
that course along the path of the nerve fiber
layer. The dimples seem to be the result of an
interplay between trauma and healing processes
constrained by nerve fiber layer and do not
appear to be due to any dissociation of optic
nerve fibers. Furthermore, thickening of the
macula without foveal depression has been
found in 84% of eyes of ILM-peeled eyes, com-
pared to 43% of eyes with unpeeled ILMs [10].
The authors of that study hypothesized that
ILM peeling could damage the Mu¨ller cell
footplates which form the inverted cone scaf-
fold that gives the navel shape to the fovea.
CONCLUSIONS
In conclusion, peeling of the ILM during ERM
removal is not necessary in terms of postoper-
ative outcome. In the present study, patients in
both treatment groups (ERM only group, ERM/
ILM peel group) achieved a similar postopera-
tive decrease in CMT and improvement in
BCVA. However, although not statistically sig-
nificant, patients in the ERM only group
showed only a tendency to have more persistent
cystoid macular edema postoperatively (inci-
dence of pCME in ERM only peel group was
22.2% vs. 12.9% in the ERM/ILM peel group;
p = 0.23). The use of intraoperative triamci-
nolone appears to be associated with lower
occurrence of persistent CME. Not one single
patient had to be re-operated due to re-occur-
rence of ERM. However, because of the rela-
tively short follow-up time, we cannot
completely exclude re-occurrence of ERM over
the long term. We therefore recommend
assessing the presence of cortical vitreous on the
ILM after having first removed the ERM. If there
is residual vitreous, peeling of the ILM is indi-
cated to prevent re-proliferation of ERM. Sur-
geons must also consider whether the ILM is
intact or damaged after ERM removal. If the ILM
is not damaged, the surgeon may decide to
leave it; if it is damaged or responsible for reti-
nal striae, removal may offer more complete
relief of traction. The surgeon should avoid ILM
removal in cases of retinal thinning in patients
with circulatory or metabolic disorders
[4, 18, 19, 20].
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